Investigation of Embryoscopy in Recurrent Pregnancy Loss
Recurrent Miscarriage
About this trial
This is an interventional diagnostic trial for Recurrent Miscarriage focused on measuring Embryoscopy, recurrent miscarriage, missed abortion, Structural anomalies in recurrent miscarriage, Embryoscopically directed biopsy for karyotyping
Eligibility Criteria
Inclusion Criteria: Recurrent miscarriage, (at least 2 consecutive miscarriages) Confirmation of missed abortion by ultrasound At least 5 1/2 weeks of gestation D & C is clinically indicated Exclusion Criteria: Sporadic miscarriages Less than two consecutive miscarriages. If D & C is not clinically indicated
Sites / Locations
- Herzlia Medical Center
- Sheba Medical Center
Arms of the Study
Arm 1
Experimental
1
Embryoscopy will be evaluated in women with at least two previous miscarriages, after confirmation of missed abortion by ultrasound. Embryoscopy will only be performed in patients in whom curettage is clinically indicated, and will only be added to the D&C if there is a possibility of visualizing embryonic tissue, i:e. from approximately 5½ weeks onwards when there is an embryonic pole detected on ultrasound.